Gufic Biosciences Limited (NSE:GUFICBIO)
India flag India · Delayed Price · Currency is INR
383.65
+22.60 (6.26%)
Apr 24, 2025, 3:29 PM IST

Gufic Biosciences Statistics

Total Valuation

NSE:GUFICBIO has a market cap or net worth of INR 38.52 billion. The enterprise value is 41.29 billion.

Market Cap 38.52B
Enterprise Value 41.29B

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date May 29, 2025
Ex-Dividend Date Sep 17, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +2.69%
Shares Change (QoQ) -0.29%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 24.74M

Valuation Ratios

The trailing PE ratio is 46.99.

PE Ratio 46.99
Forward PE n/a
PS Ratio 4.76
PB Ratio 6.71
P/TBV Ratio 6.78
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 50.36
EV / Sales 5.10
EV / EBITDA 29.54
EV / EBIT 32.44
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.52
Debt / EBITDA 2.12
Debt / FCF n/a
Interest Coverage 7.25

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 9.82%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 5.43M
Profits Per Employee 549,805
Employee Count 1,491
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +19.65% in the last 52 weeks. The beta is 0.72, so NSE:GUFICBIO's price volatility has been lower than the market average.

Beta (5Y) 0.72
52-Week Price Change +19.65%
50-Day Moving Average 356.00
200-Day Moving Average 397.10
Relative Strength Index (RSI) 65.48
Average Volume (20 Days) 67,784

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:GUFICBIO had revenue of INR 8.10 billion and earned 819.76 million in profits. Earnings per share was 8.17.

Revenue 8.10B
Gross Profit 4.27B
Operating Income 1.27B
Pretax Income 1.11B
Net Income 819.76M
EBITDA 1.33B
EBIT 1.27B
Earnings Per Share (EPS) 8.17
Full Income Statement

Balance Sheet

The company has 193.96 million in cash and 2.96 billion in debt, giving a net cash position of -2.77 billion.

Cash & Cash Equivalents 193.96M
Total Debt 2.96B
Net Cash -2.77B
Net Cash Per Share n/a
Equity (Book Value) 5.74B
Book Value Per Share 57.24
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 52.78%, with operating and profit margins of 15.72% and 10.12%.

Gross Margin 52.78%
Operating Margin 15.72%
Pretax Margin 13.68%
Profit Margin 10.12%
EBITDA Margin 16.38%
EBIT Margin 15.72%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.

Dividend Per Share 0.10
Dividend Yield 0.03%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.69%
Shareholder Yield -2.66%
Earnings Yield 2.13%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a